Open Label Long Term Clinical Trial Evaluating Efficacy and Safety of Chronic Therapy with Certolizumab Pegol, a PEGylated Fab Fragment of Humanized Antibody to Tumor Necrosis Factor Alpha (TNF) in Patients Suffering from Crohn's Disease

  • De Villiers, Willem (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/077/31/10